PharmaEssentia at SITC 2026
Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website
PharmaEssentia brings 2 presentations to SITC 2026 in Phoenix. Its program centres on early-stage drug candidates that reprogram myeloid cells or steer IL-2 toward immune cells. Its IL-2 candidate is aimed at PD-1 and shows anti-tumor activity with a favorable safety profile in preclinical tests.
| Organization | SITC 2026 Attendance |
|---|---|
PharmaEssentia Taipei, Taiwan | |
A biopharmaceutical company developing treatments for cancer and other diseases. | Poster Fri Nov 6 12:15–1:45pm 5:30–7pm |
Instantly find 20 buyers from PharmaEssentia
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the Society for Immunotherapy of Cancer (SITC). Submit a correction